SZÚ

Contacts


The National Institute of Public Health
Šrobárova 49/48
100 00, Praha 10

Phone: 00420 26708 1111
E-mail: podatelna@szu_cz

Home » ECDC - project HERA
Stáhnout článek jako PDF Vytisknout

ECDC - project HERA


Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in the Czech Republic.

Name of the Project: Grant/2021/PHF/23776 - Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in the Czech Republic.

Grant Number: ECDC/HERA/2021/004 ECD.12218

Project Duration: from 03/09/2021 to 30/9/2022

Funding: The European Centre for Disease Prevention and Control (ECDC)  

Grant: Grant/2021/PHF/23776

The Name of the Call: Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in the European Union and European Economic Area

Beneficiary: National Institute of Public Health

Affiliated Entities:

  • Public Health Institute Ostrava
  • Public Health Institute Ústí nad Labem
  • Faculty of Science, Charles University
  • Institute of Molecular Genetics of the Czech Academy of Sciences
  • Biology Centre, Czech Academy of Sciences
  • Centre for Infectious Animal Diseases in Czech University of Life Science Prague
  • The Institute of Molecular and Translational Medicine

The action „Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in the Czech Republic“has received funding from the European Centre for Disease Prevention and Control (ECDC) under GRANT/2021/PHF/23776. 

 

Project Goals:

The general objective of the action is to enhance and/or improve national public health WGS and/or RT-PCR capacity. Results should be directed, tailored and contributing towards the following expected outcomes:

  • In the short-term, contribution to the establishment of a sustainable, efficient and high capacity WGS and/or RT-PCR infrastructure for national public health microbiology;
  • In the short/medium-term, contribution to early detection and enhanced monitoring of emergent and known SARS-CoV-2 variants at the national and the EU/EEA levels;
  • In the medium/long-term, contribution to enhanced genomic-based infectious disease outbreak investigation capacities at regional, national and/or EU/EEA levels;
  • In the medium/long-term, contribution to enhanced routine genomic-based surveillance of infectious diseases at the regional, national and/or EU/EEA levels, in accordance with the “ECDC strategic framework for the integration of molecular and genomic typing into European surveillance and multi-country outbreak investigations”; and
  • In the long-term, contribution to enhanced preparedness for timely and effective response in cross-border outbreaks of infectious diseases and pandemics.

 

Contact Person Responsible for the Application

RNDr. Helena Jiřincová, tel.:267082421, e-mail: helena.jirincova@szu_cz

 

Project Publicity

Project related press releases in the Czech language only

Up